临床肝胆病杂志2018，Vol.34Issue(6)：1152-1155,4.DOI:10.3969/j.issn.1001-5256.2018.06.002
我国药物性肝损伤流行病学研究现状
Current status of epidemiological studies on drug-induced liver injury in China
沈弢 1黄昕 1王誉雅 1庄辉1
作者信息
- 1. 北京大学医学部基础医学院,北京100191
- 折叠
摘要
Abstract
Drug -induced liver injury (DILI) has been taken more and more seriously by governmental authorities , pharmaceutical companies,clinical physicians, and the general public.An understanding of the incidence, and distribution of DILI and related drugs is helpful for the prevention, clinical diagnosis, and treatment of DILI and may also help the government to perfect related laws and regulations and reduce the incidence of adverse drug reactions .This article reviews the epidemiology of DILI in China .关键词
药物性肝损伤/中草药/抗结核药/流行病学Key words
drug -induced liver diseases/drugs/Chinese herbal/antitubercular agents/epidemiology分类
医药卫生引用本文复制引用
沈弢,黄昕,王誉雅,庄辉..我国药物性肝损伤流行病学研究现状[J].临床肝胆病杂志,2018,34(6):1152-1155,4.
